$239.00 Original price was: $239.00.$63.00Current price is: $63.00.
Authored by Lorenzo Galluzzi, “Immune Checkpoint Biology in Health and Disease, Volume 382” offers an in-depth analysis of the latest advancements in immune-checkpoint biology research and its implications for immunotherapy, particularly in the context of cancer.
This volume delves into the cutting-edge technologies being developed to apply immune checkpoint blockers effectively. It discusses the potential benefits and challenges associated with these novel approaches, providing insights into the future of cancer treatment.
The book also explores the next-generation deconvolution of transcriptomic data, aiming to investigate the tumor microenvironment in greater detail. This section highlights the importance of understanding the complex interactions within the tumor microenvironment for the development of effective immunotherapies.
Furthermore, the volume covers the role of immune checkpoints in targeting dendritic cells for antibody-based modulation in cancer. This section emphasizes the potential of dendritic cells as a key component in the development of novel immunotherapeutic strategies.
One of the primary focuses of the book is the interplay between immune checkpoint biology and autoimmunity in cancer patients. It discusses how an understanding of this interplay can inform the development of more targeted and effective treatment strategies.
The book also reviews recent advancements in tumor microenvironment landscaping for target selection and response prediction in immune checkpoint therapies. This section highlights the importance of spatial protein multiplexing analysis in this context.
Additionally, the volume explores immune modulation during anti-cancer radio(immuno)therapy, shedding light on the complex interactions between radiation therapy and the immune system. This section discusses the potential for combining these two approaches to achieve better treatment outcomes.
Finally, the book covers the use of preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy. This section emphasizes the potential benefits of this approach in enhancing the efficacy of immunotherapies.
“Immune Checkpoint Biology in Health and Disease, Volume 382” provides comprehensive reviews from leading experts in the field, offering valuable insights into the latest research and its implications for immunology and immunotherapy. With its cutting-edge discussions and useful schematic material, this volume is an essential resource for researchers, clinicians, and students seeking to understand the complex interplay between immune checkpoint biology and disease.
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline